KraneShares Hang Seng TECH Index ETF vs Nuwellis Inc — how do they compare? KraneShares Hang Seng TECH Index ETF trades at $11.82 (market cap $45.04M), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: KraneShares Hang Seng TECH Index ETF is far larger — about 20.5× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 29,043). Which is the better fit depends on your goals — on Pluang, investors hold KraneShares Hang Seng TECH Index ETF for 44 Days and Nuwellis Inc for 26 Days on average.
| KTEC | NUWE | |
|---|---|---|
Market Cap | $45.04M | $2.20M |
Volume | 29,043 | 121,544 |
Sector | Sector/Thematic | Health |
52-Week High | $18.73 | $146.65 |
52-Week Low | $11.41 | $0.68 |
Typical Hold Time | 44 Days | 26 Days |
Enterprise Value | — | -$1.52M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →